University of California San Francisco
Give to UCSF
When doctors accept meals from pharmaceutical salespeople, they are much more likely to prescribe the drugs the representatives are promoting than cheaper generic alternatives, UCSF researchers found .
Researchers have identified a pair of tarantula toxins that target a previously unknown pain pathway in sensory nerves.
A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug with the power to outsmart drug-resistant cancers.
With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.
UCSF researchers are using big data to find cancer treatments by mapping gene networks and screening existing cancer drugs to test their effectiveness against dozens of different cancer gene variants.
Leslie Z. Benet, PhD, a professor in the UCSF School of Pharmacy, has received the highest accolade bestowed by the American Pharmacists Association.
Finding the right dose for each patient is complex, and incorrect dosing can have major consequences. Researchers in the UCSF School of Pharmacy are finding new ways to harness the power of big data, building effective dosing models that allow for precisely individualized medicine.
Children and young adults with severe forms of epilepsy that does not respond to standard antiepileptic drugs have fewer seizures when treated with purified cannabinoid, according to a multi-center study led by researchers from UCSF Benioff Children’s Hospital San Francisco.
James Wells, PhD, chair of Pharmaceutical Chemistry, has been elected as a fellow to the prestigious National Academy of Inventors.
A team of researchers at UCSF has devised a new approach for early stage drug discovery that uses techniques from the world of computer vision in combination with a powerful new tool.
It is worthwhile to give patients expensive new drugs that can cure their hepatitis C much earlier than some insurers are now willing to pay for them, according to a UCSF study.
Scientists at the UNC School of Medicine (UNC) and UCSF have created a general tool to probe the activity of orphan receptors, illuminating their roles in behavior and making them accessible for drug discovery.
A chemical that could potentially be used in eye drops to reverse cataracts has been identified by a team of scientists from UCSF, the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).
UCSF ranks among the top five schools in the world in seven subject areas, according to the 2015 U.S. News & World Report's 2016 Best Global Universities rankings.
A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN), a consortium comprising research groups from UCSF, the University of Chicago and the University of Toronto, will support the development of next-generation, antibody-based cancer therapies.